Biased usage of T cell receptor β-chain variable region genes of Wilms’ tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination

(2011) C. Pospori et al.   BLOOD

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

(2010) K. Rezvani et al.   HAEMATOLOGICA

Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer

(2010) Miho Kaida et al.   JOURNAL OF IMMUNOTHERAPY

Biased usage of BV gene families of T-cell receptors of WT1 (Wilms’ tumor gene)-specific CD8+T cells in patients with myeloid malignancies

(2009) Yukie Tanaka-Harada et al.   CANCER SCIENCE

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Impaired Lymphocyte Responses and Their Restoration in Oral Cancer Patients Expressing Distinct TCR Variable Region

(2008) Persis Wadia et al.   CANCER INVESTIGATION